These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

602 related items for PubMed ID: 32187163

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prediction of Occult Lymph Node Metastasis Using Tumor-to-Blood Standardized Uptake Ratio and Metabolic Parameters in Clinical N0 Lung Adenocarcinoma.
    Ouyang ML, Tang K, Xu MM, Lin J, Li TC, Zheng XW.
    Clin Nucl Med; 2018 Oct; 43(10):715-720. PubMed ID: 30106864
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Predictive value of metabolism and its heterogeneity parameters measured by preoperative 18 F-FDG PET/CT for mediastinal occult lymph node metastasis in cN0 lung invasive adenocarcinoma.
    Yang Z, Liu Z, Zhang S, Qiu B, Chai H, Wei L, Li N, He Z, Luo Y, Wei H, Gan M, Xiao G.
    Hell J Nucl Med; 2024 Oct; 27(2):78-84. PubMed ID: 39097804
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer.
    Aktas GE, Karamustafaoğlu YA, Balta C, Süt N, Sarikaya İ, Sarikaya A.
    Nucl Med Commun; 2018 Nov; 39(11):995-1004. PubMed ID: 30188416
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The value on SUV-derived parameters assessed on 18F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer.
    Liao X, Liu M, Li S, Huang W, Guo C, Liu J, Xiong Y, Zhang J, Fan Y, Wang R.
    BMC Med Imaging; 2023 Apr 05; 23(1):49. PubMed ID: 37020286
    [Abstract] [Full Text] [Related]

  • 8. Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer.
    Hughes DJ, Josephides E, O'Shea R, Manickavasagar T, Horst C, Hunter S, Tanière P, Nonaka D, Van Hemelrijck M, Spicer J, Goh V, Bille A, Karapanagiotou E, Cook GJR.
    Eur Radiol; 2024 Sep 05; 34(9):5889-5902. PubMed ID: 38388716
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
    Zhai X, Guo Y, Qian X.
    Med Sci Monit; 2020 Jun 02; 26():e922675. PubMed ID: 32483109
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prediction of occult lymph node metastasis using SUV, volumetric parameters and intratumoral heterogeneity of the primary tumor in T1-2N0M0 lung cancer patients staged by PET/CT.
    Ouyang ML, Xia HW, Xu MM, Lin J, Wang LL, Zheng XW, Tang K.
    Ann Nucl Med; 2019 Sep 02; 33(9):671-680. PubMed ID: 31190182
    [Abstract] [Full Text] [Related]

  • 14. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
    Moon SH, Kim HS, Hyun SH, Choi YS, Zo JI, Shim YM, Lee KH, Kim BT, Choi JY.
    J Nucl Med; 2014 May 02; 55(5):743-8. PubMed ID: 24700884
    [Abstract] [Full Text] [Related]

  • 15. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
    Muto J, Hida Y, Kaga K, Ohtaka K, Okamoto S, Tamaki N, Nakada-Kubota R, Hirano S, Matsui Y.
    Anticancer Res; 2014 Feb 02; 34(2):805-10. PubMed ID: 24511016
    [Abstract] [Full Text] [Related]

  • 16. The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer.
    Hua J, Li L, Liu L, Liu Q, Liu Y, Chen X.
    Nucl Med Commun; 2021 Nov 01; 42(11):1247-1253. PubMed ID: 34269750
    [Abstract] [Full Text] [Related]

  • 17. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
    Park SY, Yoon JK, Park KJ, Lee SJ.
    Cancer Imaging; 2015 Dec 22; 15():21. PubMed ID: 26694918
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
    Lyu L, Liu Y, Wang XY, Zhang ZK, Tao XL, Yang L, Wu N.
    Zhonghua Zhong Liu Za Zhi; 2019 Jun 23; 41(6):441-447. PubMed ID: 31216830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.